IARC2017 - Exciting research to increase frataxin in patients with friedreich's ataxia
IARC2017 - Interviews with the Researchers:
CRISPR/Cas9 genome-wide screen to identify new targets for Friedrieichs Ataxia
Exciting genetic discovery research aims to knock-out all human genes to identify targets which can increase frataxin at the University of Oxford, UK in collaboration with Pfizer, Ataxia UK & FARA
IARC 2017 Poster: Richard Wade-Martins MA DPhil Professor of Molecular Neuroscience, Oxford University, UK
